Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma.
Huang HH, Ferguson ID, Thornton AM, Bastola P, Lam C, Lin YT, Choudhry P, Mariano MC, Marcoulis MD, Teo CF, Malato J, Phojanakong PJ, Martin TG 3rd, Wolf JL, Wong SW, Shah N, Hann B, Brooks AN, Wiita AP.
Huang HH, et al. Among authors: teo cf.
Nat Commun. 2020 Apr 22;11(1):1931. doi: 10.1038/s41467-020-15521-4.
Nat Commun. 2020.
PMID: 32321912
Free PMC article.